Nosocomial imipenem-resistant Acinetobacter baumannii infections: Epidemiology and risk factors

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 10, 2010, Pages 741-746

  Dizbay, Murat ^a   Tunccan, Ozlem Guzel ^a   Sezer, Busra Ergut ^a   Hizel, Kenan ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL STRAIN; BLOODSTREAM INFECTION; FEMALE; HEMODIALYSIS; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; RETROSPECTIVE STUDY; RISK FACTOR; SENESCENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; IMIPENEM; INCIDENCE; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, BACTERIAL; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 77956807999     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.489568     Document Type: Article

References (24)

1. Hanlon GW. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting. Lett Appl Microbiol 2005;41:375-378
2. Maragakis LL-Perl TM. Acinetobacter baumannii: epidemiology-antimicrobial resistance-and treatment options. Clin Infect Dis 2008;46:1254-1263
3. Baran G-Erbay A-Bodur H-Onguru P-AkinciE-Balaban N-et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumanniiinfections. Int J Infect Dis 2008;12:16-21.
4. Cisneros JM-Rodriguez-Bano J-Fernandez-Cuenca F-Ribera A-Vila J-Pascual A-et al. Spanish Group for Nosocomial Infection (GEIH) for the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC): Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumanniiin Spain: a nationwide study. Clin Microbiol Infect 2005;11:874-879
5. Lee SO-Kim NJ-ChoiSH-Hyong Kim T-Chung JW-Woo JH-et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004;48:224-228
6. Playford EG-Craig JC-Iredell JR. Carbapenem-resistant Acinetobacter baumanniiin intensive care unit patients: risk factors for acquisition-infection and their consequences. J Hosp Infect 2007;65:204-211
7. Garner JS-Jarvis WR-EmoriTG-Horan TC-Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-140
8. Horan TC-Gaynes RP-Martone WJ-Jarvis WR-EmoriTG. CDC definitions of nosocomial surgical site infection-1992: a modification of CDC definition of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-608
9. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 15 th Informational supplement. M100-S15. Wayne-PA: CLSI; 2005.
10. Rodriguez-Bano J-Cisneros JM-Fernandez-Cuenca F-Ribera A-Vila J-Pascual A-et al. Grupo de Estudio de Infecciõ n Hospitalaria (GEIH): Clinical features and epidemiology of Acinetobacter baumanniicolonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol 2004;25: 819-824
11. Apisarnthanarak A-PinitchaiU-Thongphubeth K-Yuekyen C-Warren DK-Fraser VJ. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumanniicolonization and infection in 3 intensive care units in a Thaitertiary care center: a 3-year study. Clin Infect Dis 2008;47:760-767
12. Turner PJ-Greenhalgh JM. The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals-1997-2000. Clin Microbiol Infect 2003;9:563-567
13. Gales AC-Jones RN-Forward KR-Liñares J-Sader HS-Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns-epidemiological features-and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001;32(Suppl 2):104-113
14. Yucesoy M-Yulug N-Kocagoz S-Unal S-Cetin S-Calangu S. Antimicrobial resistance of Gram-negative isolates from intensive care units in Turkey: comparison to previous three years. J Chemother 2000;12:294-298 (Pubitemid 30640382)
15. Aksaray S-Dokuzoguz B-Guvener E-Yucesoy M-Yulug N-Kocagoz S-et al. Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in eight hospitals in Turkey. J Antimicrob Chemother 2000; 45:695-699 (Pubitemid 30255654)
16. Korten V-Ulusoy S-Zarakolu P-Mete B. Turkish MYSTIC Study Group: Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program. Diagn Microbiol Infect Dis 2007;59:453-457
17. del Mar Tomas M-Cartelle M-Pertega S-Beceiro A-Llinares P-Canle D-et al. Hospital outbreak caused by a carbapenemresistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 2005;11:540-546
18. Ferrara AM. Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int J Antimicrob Agents 2006;27:183-195
19. Garnacho-Montero J-Ortiz-Leyba C-Fernãn dez-Hinojosa E-Aldab õ -Pall ãs T. Acinetobacter baumanniiventilator-associated pneumonia: epidemiological and clinical findings. Int Care Med 2005;31:649-655
20. C lark NM-Patterson J-Lynch PJ III. Antimicrobial resistance among Gram-negative organisms in the intensive care unit. Curr Opin Crit Care 2003;9:413-423
21. Chastre J. Infections due to Acinetobacter baumanniiin the ICU. Semin Respir Crit Care Med 2003;24:69-78.
22. Fluit AC-Jones ME-Schmitz FJ-Acar J-Gupta R-Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program-1997 and 1998. Clin Infect Dis 2000;30:454-460
23. Dizbay M-Altuncekic A-Sezer BE-Ozdemir K-Arman D. Colistin and tigecycline susceptibility among multidrugresistant Acinetobacter baumanniiisolated from ventilatorassociated pneumonia. Int J Antimicrob Agents 2008;32: 29-32.
24. Sader HS-Jones RN-Dowzicky MJ-Fritsche TR. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn Microbiol Infect Dis 2005;52: 203-208